GlaxoSmithKline PLC Interest Coverage Over Time

GSK -  USA Stock  

USD 39.84  0.73  1.80%

With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Please check GlaxoSmithKline PLC Performance and GlaxoSmithKline PLC Correlation.

Search Competitors Fundamentals Over Time Against Interest Coverage 

 
Refresh
The current Interest Coverage is estimated to increase to 7.51, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are projected to decrease to under 10 B.
The market value of GlaxoSmithKline PLC is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine GlaxoSmithKline PLC value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Specify up to 10 symbols:


Cross Equities Interest Coverage Analysis

Compare GlaxoSmithKline PLC and related stocks such as Astrazeneca PLC, Bristol-Myers Squibb, Johnson Johnson, Eli Lilly And, Merck Company, Gilead Sciences, Grifols SA, Horizon Therapeutics, Abbvie Inc Interest Coverage Over Time
Select Fundamental

201020112012201320142015201620172018201920202021
AZN
25.771328.565720.26879.51795.410111.30228.42276.41715.44534.59755.97896.1362
BMY
84.057112129.736815.557812.763510.271727.724618.428627.96729.013710.3710.6421
GSK
5.697311.846710.54469.95655.284616.11773.48655.67887.25046.92025.44887.5099
JNJ
32.466732.466757.667657.667657.667657.667657.667633.5246217217217132
LLY
49.841351.419475.288514710938.601145.104639.083233.072216.611222.365922.9557
MRK
3.7513.945519.114111.091212.167418.088814.73717.704619.34518.744810.239611.4735
GILD
81.403327.297111.111114.741237.05132.257318.291512.63337.61374.30854.13724.2459
ABBV
61647369.2520.37418.723810.98699.72449.55385.57958.60374.98385.1125

GlaxoSmithKline PLC and related stocks such as Astrazeneca PLC, Bristol-Myers Squibb, Johnson Johnson, Eli Lilly And, Merck Company, Gilead Sciences, Grifols SA, Horizon Therapeutics, Abbvie Inc Interest Coverage description

My Equities

My Current Equities and Potential Positions

GSK - USA Stock
GlaxoSmithKline PLC
GSK
GlaxoSmithKline PLC Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
RegionEurope
ExchangeNew York Stock Exchange
$39.84
Please check GlaxoSmithKline PLC Performance and GlaxoSmithKline PLC Correlation. Note that the GlaxoSmithKline PLC information on this page should be used as a complementary analysis to other GlaxoSmithKline PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for GlaxoSmithKline PLC Stock analysis

When running GlaxoSmithKline PLC price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
The market value of GlaxoSmithKline PLC is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine GlaxoSmithKline PLC value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.